LATEST

• BUSINESS AbbVie Aims for Neuroscience Leadership, CSO Says in Tokyo
  October 2, 2025

• ORGANIZATION Think Tanks Urge Unique Value Framework for Regenerative Medicine in 2026 Reform
  October 2, 2025

• BUSINESS Kyorin Bags Japan Rights to Hinge Bio’s SLE Med
  October 2, 2025

• BUSINESS JCR Out-Licenses Fabry Drug to Oman’s Menagen for MENAT Region
  October 2, 2025

• BUSINESS Specialist Urges More COVID Shots for Elderly amid “13th Wave”
  October 2, 2025

• BUSINESS Sanofi Sets Sights on 2026 NIP Inclusion of RSV Drug Beyfortus in Japan
  October 2, 2025

• BUSINESS Teijin, Australian CDMO Form Alliance for Cell and Gene Therapies in Asia-Pacific
  October 2, 2025

• BUSINESS Fuji Pharma Seeks Dysmenorrhea Use for Nextstellis in Thailand
  October 2, 2025

• BUSINESS Chugai’s PiaSky Now Available in Taiwan for PNH
  October 2, 2025

• ORGANIZATION JETRO Launches Japan Entry Program for Regenerative Medicine Startups
  October 2, 2025

• BUSINESS Takeda to Reevaluate Osaka Plasma Facility Plan as Costs Mount
  October 1, 2025

• BUSINESS SSP to Roll Out Pharmacist Training Ahead of OTC Cialis Launch in Japan
  October 1, 2025

• ORGANIZATION Policy Veterans’ Group Calls for Inflation-Linked Drug Pricing in FY2026 Reform
  October 1, 2025

• BUSINESS Heartseed, Novo Nordisk End Global Cell Therapy Pact
  October 1, 2025

• BUSINESS Dalton Drops ASKA Stake Increase Plan, Slams Firm’s “Self-Preservation”
  October 1, 2025

• REGULATORY Japan Will Receive MFN Status on US Drug Tariffs: Akazawa
  October 1, 2025

• BUSINESS Nxera Earns US$10 Million Milestone from AbbVie in Neurology Deal
  October 1, 2025

• BUSINESS Santen, RemeGen Win China Filing Acceptance for RC28-E in DME
  October 1, 2025

• BUSINESS Ono Files SK Bio’s Epilepsy Med Cenobamate in Japan
  October 1, 2025

• REGULATORY MHLW Council Clears Public Knowledge Filing for MabCampath in T-PLL
  October 1, 2025

ページ

• « 先頭
• ‹ Prev
• …
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• …
• Next ›
• 最終 »